|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-4-24
|
|
pubmed:abstractText |
Harvesting of hemopoietic stem cells (HSC) from G-CSF-primed BM for autologous transplantation is an alternative to collection of unprimed BM or G-CSF-primed peripheral blood (PB). However, the optimum number of days of G-CSF administration for this purpose is unknown. We set out to determine whether cell yields could be optimized by varying the number of days of G-CSF administration prior to BM stem cell harvesting.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1465-3249
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
158-64
|
|
pubmed:dateRevised |
2008-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:17453967-Adolescent,
pubmed-meshheading:17453967-Adult,
pubmed-meshheading:17453967-Aged,
pubmed-meshheading:17453967-Antigens, CD34,
pubmed-meshheading:17453967-Bone Marrow Transplantation,
pubmed-meshheading:17453967-Cell Separation,
pubmed-meshheading:17453967-Female,
pubmed-meshheading:17453967-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:17453967-Hematopoietic Stem Cells,
pubmed-meshheading:17453967-Humans,
pubmed-meshheading:17453967-Male,
pubmed-meshheading:17453967-Middle Aged,
pubmed-meshheading:17453967-Time Factors,
pubmed-meshheading:17453967-Transplantation, Autologous
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
A randomized controlled clinical trial to determine the optimum duration of G-CSF priming prior to BM stem cell harvesting.
|
|
pubmed:affiliation |
Department of Haematology/Oncology, Royal Hobart Hospital. Hobart, Tasmania, Australia. R.M.Lowenthal@utas.edu.au
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
